You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GBM

Showing 1 - 25 of 872
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

Recruiting
  • Glioblastoma Multiforme
  • Recurrent Glioblastoma
  • TheraSphere GBM
  • San Francisco, California
  • +4 more
Aug 15, 2022

Glioblastoma, Glioblastoma Multiforme Trial (APG-157)

Available
  • Glioblastoma
  • Glioblastoma Multiforme
  • (no location specified)
Sep 19, 2022

Gut microBIOME in Glioblastoma Patients Receiving

Not yet recruiting
  • Glioblastoma, IDH-wildtype
    • (no location specified)
    Apr 5, 2022

    Glioblastoma Trial (Tofacitinib 5 MG)

    Recruiting
    • Glioblastoma
    • Tofacitinib 10mg
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jan 3, 2023

    Primary Glioblastoma Trial (AV-GBM-1, Autologous monocytes)

    Not yet recruiting
    • Primary Glioblastoma
    • AV-GBM-1
    • Autologous monocytes
    • (no location specified)
    Dec 14, 2021

    Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)

    Active, not recruiting
    • Glioblastoma Multiforme
    • VBI-1901
    • +2 more
    • Los Angeles, California
    • +3 more
    Jun 27, 2022

    Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)

    Not yet recruiting
    • Glioblastoma
    • Amyvid, Intravenous Solution
    • Bayamon, Puerto Rico
    • +1 more
    Apr 18, 2023

    Recurrent Glioblastoma Trial (Sintilimab plus Bevacizumab and Temozolomide)

    Not yet recruiting
    • Recurrent Glioblastoma
    • Sintilimab plus Bevacizumab and Temozolomide
    • (no location specified)
    Nov 27, 2022

    Kidney Failure, Acute Trial in Marseille (Apheresis technics)

    Recruiting
    • Kidney Failure, Acute
    • Apheresis technics
    • Marseille, France
      Assisatance Publique Hôpitaux de Marseille
    Mar 22, 2022

    Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

    Not yet recruiting
    • Glioblastoma Multiforme
    • +3 more
    • P140K-MGMT
    • +5 more
    • Bethesda, Maryland
    • +1 more
    Jul 4, 2022

    Glioblastoma Trial in Boston (ITI-1001)

    Not yet recruiting
    • Glioblastoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 13, 2023

    Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Stanford, California
    • +1 more
    Nov 22, 2022

    Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

    Active, not recruiting
    • Glioma
    • +4 more
    • VAL-083 (Dianhydrogalactitol)
    • Guangzhou, China
      Sun Yat-Sen University Cancer Center
    Mar 23, 2022

    Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))

    Not yet recruiting
    • Glioblastoma
    • Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
    • (no location specified)
    Apr 20, 2022

    IRD at Admission Predicts Survival of GBM Patients -Prospective

    Recruiting
    • Glioblastoma Multiforme
      • Winnipeg MB, Manitoba, Canada
      • +1 more
      Jun 8, 2022

      Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

      Recruiting
      • Anaplastic Oligoastrocytoma
      • Glioblastoma
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Oct 27, 2022

      Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

      Recruiting
      • Glioblastoma Multiforme
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 13, 2023

      Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

      Not yet recruiting
      • Glioblastoma
      • Glioma, Malignant
      • MT-201-GBM monocyte vaccine
      • Durham, North Carolina
        The Preston Robert Tisch Brain Tumor Center at Duke University M
      May 25, 2022

      Glioblastoma Trial run by the NCI (drug, biological, other)

      Completed
      • Glioblastoma
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 23, 2022

      MGMT-unmethylated Glioblastoma (GBM), GBM Trial in New York (Nivolumab, Ipilimumab, Radiation Therapy (RT))

      Completed
      Has Results
      • MGMT-unmethylated Glioblastoma (GBM)
      • GBM
      • New York, New York
        New York University School of Medicine
      Jun 30, 2022

      GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

      Completed
      Has Results
      • GBM
      • +3 more
      • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
      • Durham, North Carolina
        Duke University Medical Center
      Jun 28, 2022

      Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

      Recruiting
      • Glioblastoma
      • +3 more
      • Radiation: Intra-operative Radiation Therapy - IORT
      • +2 more
      • Santa Monica, California
        Providence Saint John's Health Center
      Jul 14, 2022

      6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

      Withdrawn
      • MGMT-Methylated Glioblastoma
      • Delay of TMZ
      • Standard of Care (SOC) Adjuvant TMZ (no intervention
      • (no location specified)
      Aug 5, 2022

      Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days

      Recruiting
      • Glioblastoma, Adult
      • Pembrolizumab at 7 days prior
      • +3 more
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Jan 17, 2023

      GBM, Glioblastoma Multiforme, Gliosarcoma Trial in Providence, Dallas (PSMA ADC)

      Completed
      Has Results
      • GBM
      • +2 more
      • PSMA ADC
      • Providence, Rhode Island
      • +1 more
      Nov 22, 2021